scholarly article | Q13442814 |
P356 | DOI | 10.1167/IOVS.12-10867 |
P8608 | Fatcat ID | release_23g5dwsebfgnlb2o4k2gtoo7yq |
P932 | PMC publication ID | 3626525 |
P698 | PubMed publication ID | 23404124 |
P5875 | ResearchGate publication ID | 235604364 |
P50 | author | Lesley F Tinker | Q85643662 |
Paul S Bernstein | Q88167571 | ||
Erin S LeBlanc | Q89239956 | ||
Robert P Igo | Q92784819 | ||
Kristin N Meyer | Q96127926 | ||
Gloria E Sarto | Q114375000 | ||
Barbara J Truitt | Q114447141 | ||
Chitra K Karki | Q114723333 | ||
Karen M Gehrs | Q58411078 | ||
Sudha Iyengar | Q64008607 | ||
P2093 | author name string | Zhe Liu | |
Michael L Klein | |||
Elizabeth J Johnson | |||
Corinne D Engelman | |||
Robert B Wallace | |||
Barbara A Blodi | |||
D Max Snodderly | |||
Julie A Mares | |||
Jennifer Robinson | |||
Gregory Hageman | |||
P2860 | cites work | Finding the missing heritability of complex diseases | Q22122198 |
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration | Q24622351 | ||
Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) | Q24622766 | ||
Identification of StARD3 as a lutein-binding protein in the macula of the primate retina | Q24628314 | ||
A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement | Q24635141 | ||
PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
Missing heritability and strategies for finding the underlying causes of complex disease | Q29614586 | ||
Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium | Q30431111 | ||
The prime role of HDL to transport lutein into the retina: evidence from HDL-deficient WHAM chicks having a mutant ABCA1 transporter | Q80853945 | ||
The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation | Q81247711 | ||
CMO1 deficiency abolishes vitamin A production from beta-carotene and alters lipid metabolism in mice | Q81250317 | ||
The ABCG5 polymorphism contributes to individual responses to dietary cholesterol and carotenoids in eggs | Q83154450 | ||
The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS | Q83211085 | ||
Macular pigment and visual performance in glare: benefits for photostress recovery, disability glare, and visual discomfort | Q83377582 | ||
Anti-inflammatory effects of lutein in retinal ischemic/hypoxic injury: in vivo and in vitro studies | Q84748765 | ||
Analysis of the macular pigment by HPLC: retinal distribution and age study | Q68367274 | ||
Dietary omega-3 fatty acids and accumulation of docosahexaenoic acid in rod photoreceptor cells of the retina and at synapses | Q68440774 | ||
The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas | Q71356050 | ||
In vivo measurement of lipofuscin in Stargardt's disease--Fundus flavimaculatus | Q71741579 | ||
Dietary modification of human macular pigment density | Q73671816 | ||
Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative | Q79340995 | ||
Apolipoprotein e gene and age-related maculopathy in older individuals: the cardiovascular health study | Q79518790 | ||
HPLC measurement of ocular carotenoid levels in human donor eyes in the lutein supplementation era | Q79655255 | ||
Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration | Q79896842 | ||
A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects | Q30844471 | ||
Influence of lutein supplementation on macular pigment, assessed with two objective techniques. | Q30929610 | ||
Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density | Q31389893 | ||
Discerning the ancestry of European Americans in genetic association studies | Q33315561 | ||
Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study | Q33400334 | ||
rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration | Q33508828 | ||
RPE65: role in the visual cycle, human retinal disease, and gene therapy | Q33652414 | ||
A CD36-related transmembrane protein is coordinated with an intracellular lipid-binding protein in selective carotenoid transport for cocoon coloration | Q33748224 | ||
Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome | Q33953350 | ||
Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration | Q34021032 | ||
A class B scavenger receptor mediates the cellular uptake of carotenoids in Drosophila | Q34075196 | ||
Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study | Q34108927 | ||
Association of macular pigment density with plasma ω-3 fatty acids: the PIMAVOSA study | Q34138412 | ||
Esterification does not impair lutein bioavailability in humans. | Q34162985 | ||
Inhibition of the visual cycle by A2E through direct interaction with RPE65 and implications in Stargardt disease. | Q34199909 | ||
Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment. | Q34278325 | ||
The impact of macular pigment augmentation on visual performance using different carotenoid formulations. | Q34310338 | ||
Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin | Q34627818 | ||
Single nucleotide polymorphisms upstream from the β-carotene 15,15'-monoxygenase gene influence provitamin A conversion efficiency in female volunteers | Q34633920 | ||
Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an Ancillary Study of the Women's Health Initiative | Q34760523 | ||
Healthy lifestyles related to subsequent prevalence of age-related macular degeneration. | Q34785911 | ||
Vitamin D status and early age-related macular degeneration in postmenopausal women | Q34786173 | ||
Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium | Q35133725 | ||
Genetic defects in vitamin A metabolism of the retinal pigment epithelium | Q35183321 | ||
Surface plasmon resonance (SPR) studies on the interactions of carotenoids and their binding proteins | Q35789333 | ||
The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study | Q36136223 | ||
Heritability of the spatial distribution and peak density of macular pigment: a classical twin study | Q36238357 | ||
The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field. | Q36317120 | ||
Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms | Q36477625 | ||
Distribution, interconversion, and dose response of n-3 fatty acids in humans | Q36536062 | ||
Xanthophylls are preferentially taken up compared with beta-carotene by retinal cells via a SRBI-dependent mechanism | Q36745022 | ||
Delta6-desaturase (FADS2) deficiency unveils the role of omega3- and omega6-polyunsaturated fatty acids | Q36862651 | ||
Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations | Q37069102 | ||
Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells | Q37098578 | ||
Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study | Q37156081 | ||
Variation in lipid-associated genes as they relate to risk of advanced age-related macular degeneration | Q37366333 | ||
Colors with functions: elucidating the biochemical and molecular basis of carotenoid metabolism | Q37736472 | ||
Marked HDL deficiency and premature coronary heart disease. | Q37771219 | ||
Retinoic acid, immunity, and inflammation | Q37854959 | ||
Genetic variations involved in interindividual variability in carotenoid status. | Q37940438 | ||
A review of the evidence germane to the putative protective role of the macular carotenoids for age-related macular degeneration | Q37961646 | ||
Importance of β,β-carotene 15,15'-monooxygenase 1 (BCMO1) and β,β-carotene 9',10'-dioxygenase 2 (BCDO2) in nutrition and health | Q37965458 | ||
The ringlike structure of macular pigment in age-related maculopathy: results from the Muenster Aging and Retina Study (MARS). | Q38462099 | ||
Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration | Q39575237 | ||
Chemistry and metabolism of lipids in the vertebrate retina | Q40154390 | ||
Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process | Q40207342 | ||
Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. | Q40736925 | ||
Absorption, metabolism, and transport of carotenoids. | Q40981969 | ||
Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation | Q42164095 | ||
Lutein transport by Caco-2 TC-7 cells occurs partly by a facilitated process involving the scavenger receptor class B type I (SR-BI). | Q42470830 | ||
The relation between the macular carotenoids, lutein and zeaxanthin, and temporal vision | Q43056971 | ||
Patients with Sjögren-Larsson syndrome lack macular pigment. | Q43158883 | ||
Apolipoprotein E genotype is associated with macular pigment optical density | Q43182517 | ||
Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women's health initiative | Q43881495 | ||
Identification and functional analysis of a naturally occurring E89K mutation in the ABCA1 gene of the WHAM chicken. | Q44168282 | ||
Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study | Q44212321 | ||
Neuroprotective effect of an antioxidant, lutein, during retinal inflammation | Q44386863 | ||
Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial | Q44696848 | ||
Macular pigment measurement by heterochromatic flicker photometry in older subjects: the carotenoids and age-related eye disease study. | Q44743294 | ||
Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study | Q44925974 | ||
Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. | Q45050501 | ||
Morphologic and electroretinographic phenotype of SR-BI knockout mice after a long-term atherogenic diet. | Q46023211 | ||
Substrate specificity of a recombinant chicken beta-carotene 15,15'-monooxygenase that converts beta-carotene into retinal | Q46268458 | ||
Assessment of ocular exposure to visible light for population studies | Q46450625 | ||
Nutritional manipulation of primate retinas. IV. Effects of n--3 fatty acids, lutein, and zeaxanthin on S-cones and rods in the foveal region | Q46509948 | ||
Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe | Q46715258 | ||
Macular pigment and visual performance under glare conditions | Q46736128 | ||
Heritability of macular pigment: a twin study | Q46816863 | ||
Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. | Q50268024 | ||
Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study. | Q50474439 | ||
Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance. | Q50478568 | ||
Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. | Q50495142 | ||
Genetic variants in BCMO1 and CD36 are associated with plasma lutein concentrations and macular pigment optical density in humans. | Q51386596 | ||
The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype. | Q54355696 | ||
Effect of Mediterranean diet on the expression of pro-atherogenic genes in a population at high cardiovascular risk | Q59158036 | ||
Dose-Ranging Study of Lutein Supplementation in Persons Aged 60 Years or Older | Q59325038 | ||
Variability of Serum Carotenoids in Response to Controlled Diets Containing Six Servings of Fruits and Vegetables per Day | Q63339774 | ||
Associations Between Intermediate Age-Related Macular Degeneration and Lutein and Zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS) | Q63344335 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
P304 | page(s) | 2333-2345 | |
P577 | publication date | 2013-03-28 | |
P1433 | published in | Investigative Ophthalmology Visual Science | Q6060707 |
P1476 | title | Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study | |
P478 | volume | 54 |
Q28512836 | A genetic dissection of intestinal fat-soluble vitamin and carotenoid absorption |
Q64244676 | Assessment of Macular Pigment Optical Density Using Fundus Reflectometry in Diabetic Patients |
Q38884071 | Association between Dietary Xanthophyll (Lutein and Zeaxanthin) Intake and Early Age-Related Macular Degeneration: The Atherosclerosis Risk in Communities Study |
Q36826507 | Association between vitamin D status and age-related macular degeneration by genetic risk |
Q31143690 | Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor study |
Q34185581 | Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study |
Q37686531 | Brain xanthophyll content and exploratory gene expression analysis: subspecies differences in rhesus macaque |
Q37286511 | Candidate gene study of macular response to supplemental lutein and zeaxanthin |
Q35801527 | Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements |
Q64928522 | Dietary Antioxidants, Macular Pigment, and Glaucomatous Neurodegeneration: A Review of the Evidence. |
Q47106416 | Dietary guidance for lutein: consideration for intake recommendations is scientifically supported |
Q47253521 | Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial |
Q57163177 | Effect of age and other factors on macular pigment optical density measured with resonance Raman spectroscopy |
Q38220379 | Effects of light quality on the accumulation of phytochemicals in vegetables produced in controlled environments: a review |
Q37537304 | Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS). |
Q90319865 | Hepatic Vitamin A Concentrations in Vervets (Chlorocebus aethiops) Supplemented with Carotenoids Derived from Oil Palm |
Q39094660 | Host-related factors explaining interindividual variability of carotenoid bioavailability and tissue concentrations in humans |
Q33925653 | Inactivity of human β,β-carotene-9',10'-dioxygenase (BCO2) underlies retinal accumulation of the human macular carotenoid pigment |
Q30829406 | Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up |
Q57177518 | Intrinsic and Extrinsic Factors Impacting Absorption, Metabolism, and Health Effects of Dietary Carotenoids |
Q36468066 | Joint Associations of Diet, Lifestyle, and Genes with Age-Related Macular Degeneration |
Q34733171 | Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study |
Q47141535 | Lutein accumulates in subcellular membranes of brain regions in adult rhesus macaques: Relationship to DHA oxidation products. |
Q38901504 | Lutein and Zeaxanthin Isomers in Eye Health and Disease |
Q52588804 | Lutein, zeaxanthin and mammalian development: Metabolism, functions and implications for health. |
Q30693939 | Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease |
Q37636009 | Macular Pigment Optical Density and Measures of Macular Function: Test-Retest Variability, Cross-Sectional Correlations, and Findings from the Zeaxanthin Pilot Study of Response to Supplementation (ZEASTRESS-Pilot). |
Q35542894 | Macular pigment optical density in a healthy Chinese population |
Q47834614 | Macular pigment optical density is positively associated with academic performance among preadolescent children |
Q28240096 | Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration |
Q38921719 | Plasma long-chain omega-3 polyunsaturated fatty acids and macular pigment in subjects with family history of age-related macular degeneration: the Limpia Study |
Q37715993 | Potential protective function of the sterol regulatory element binding factor 1-fatty acid desaturase 1/2 axis in early-stage age-related macular degeneration |
Q48251018 | RPE65 takes on another role in the vertebrate retina |
Q52782567 | Retinal accumulation of zeaxanthin, lutein, and β-carotene in mice deficient in carotenoid cleavage enzymes. |
Q88615813 | Supplementation with macular carotenoids improves visual performance of transgenic mice |
Q35596762 | The Effect of BCMO1 Gene Variants on Macular Pigment Optical Density in Young Healthy Caucasians. |
Q35106624 | The relationship between BCMO1 gene variants and macular pigment optical density in persons with and without age-related macular degeneration |
Q90240716 | β-carotene in Obesity Research: Technical Considerations and Current Status of the Field |
Search more.